TY - JOUR AU - Antoni, S. AU - Ferlay, J. AU - Soerjomataram, I. AU - Znaor, A. AU - Jemal, A. AU - Bray, F. PY - 2017 DA - 2017// TI - Bladder cancer incidence and mortality: a global overview and recent trends JO - Eur Urol VL - 71 UR - https://doi.org/10.1016/j.eururo.2016.06.010 DO - 10.1016/j.eururo.2016.06.010 ID - Antoni2017 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2020 DA - 2020// TI - Cancer statistics, 2020 JO - CA Cancer J Clin VL - 70 UR - https://doi.org/10.3322/caac.21590 DO - 10.3322/caac.21590 ID - Siegel2020 ER - TY - JOUR AU - Knowles, M. A. AU - Hurst, C. D. PY - 2015 DA - 2015// TI - Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc3817 DO - 10.1038/nrc3817 ID - Knowles2015 ER - TY - JOUR AU - Alfred Witjes, J. AU - Lebret, T. AU - Comperat, E. M. AU - Cowan, N. C. AU - Santis, M. AU - Bruins, H. M. PY - 2017 DA - 2017// TI - Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer JO - Eur Urol VL - 71 UR - https://doi.org/10.1016/j.eururo.2016.06.020 DO - 10.1016/j.eururo.2016.06.020 ID - Alfred Witjes2017 ER - TY - JOUR AU - Lodewijk, I. AU - Duenas, M. AU - Rubio, C. AU - Munera-Maravilla, E. AU - Segovia, C. AU - Bernardini, A. PY - 2018 DA - 2018// TI - Liquid biopsy biomarkers in bladder cancer: a current need for patient diagnosis and monitoring JO - Int J Mol Sci. VL - 19 UR - https://doi.org/10.3390/ijms19092514 DO - 10.3390/ijms19092514 ID - Lodewijk2018 ER - TY - JOUR AU - Ark, J. T. AU - Keegan, K. A. AU - Barocas, D. A. AU - Morgan, T. M. AU - Resnick, M. J. AU - You, C. PY - 2014 DA - 2014// TI - Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy JO - BJU Int. VL - 113 UR - https://doi.org/10.1111/bju.12245 DO - 10.1111/bju.12245 ID - Ark2014 ER - TY - JOUR AU - Kulkarni, G. S. AU - Hakenberg, O. W. AU - Gschwend, J. E. AU - Thalmann, G. AU - Kassouf, W. AU - Kamat, A. PY - 2010 DA - 2010// TI - An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer JO - Eur Urol VL - 57 UR - https://doi.org/10.1016/j.eururo.2009.08.024 DO - 10.1016/j.eururo.2009.08.024 ID - Kulkarni2010 ER - TY - JOUR AU - Svatek, R. S. AU - Hollenbeck, B. K. AU - Holmang, S. AU - Lee, R. AU - Kim, S. P. AU - Stenzl, A. PY - 2014 DA - 2014// TI - The economics of bladder cancer: costs and considerations of caring for this disease JO - Eur Urol VL - 66 UR - https://doi.org/10.1016/j.eururo.2014.01.006 DO - 10.1016/j.eururo.2014.01.006 ID - Svatek2014 ER - TY - JOUR AU - Babjuk, M. AU - Bohle, A. AU - Burger, M. AU - Capoun, O. AU - Cohen, D. AU - Comperat, E. M. PY - 2017 DA - 2017// TI - EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016 JO - Eur Urol VL - 71 UR - https://doi.org/10.1016/j.eururo.2016.05.041 DO - 10.1016/j.eururo.2016.05.041 ID - Babjuk2017 ER - TY - JOUR AU - Robertson, A. G. AU - Kim, J. AU - Al-Ahmadie, H. AU - Bellmunt, J. AU - Guo, G. AU - Cherniack, A. D. PY - 2017 DA - 2017// TI - Comprehensive molecular characterization of muscle-invasive bladder cancer JO - Cell VL - 171 ID - Robertson2017 ER - TY - JOUR AU - Baylin, S. B. AU - Jones, P. A. PY - 2016 DA - 2016// TI - Epigenetic determinants of cancer JO - Cold Spring Harb Perspect Biol. VL - 8 UR - https://doi.org/10.1101/cshperspect.a019505 DO - 10.1101/cshperspect.a019505 ID - Baylin2016 ER - TY - JOUR AU - Jeronimo, C. AU - Henrique, R. PY - 2014 DA - 2014// TI - Epigenetic biomarkers in urological tumors: a systematic review JO - Cancer Lett VL - 342 UR - https://doi.org/10.1016/j.canlet.2011.12.026 DO - 10.1016/j.canlet.2011.12.026 ID - Jeronimo2014 ER - TY - JOUR AU - Cooper, D. N. PY - 1983 DA - 1983// TI - Eukaryotic DNA methylation JO - Hum Genet VL - 64 UR - https://doi.org/10.1007/BF00292363 DO - 10.1007/BF00292363 ID - Cooper1983 ER - TY - JOUR AU - Weisenberger, D. J. PY - 2014 DA - 2014// TI - Characterizing DNA methylation alterations from the cancer genome atlas JO - J Clin Invest. VL - 124 UR - https://doi.org/10.1172/JCI69740 DO - 10.1172/JCI69740 ID - Weisenberger2014 ER - TY - JOUR AU - van der Heijden, A. G. AU - Mengual, L. AU - Ingelmo-Torres, M. AU - Lozano, J. J. AU - van Rijt-van de Westerlo, C. C. M. AU - Baixauli, M. PY - 2018 DA - 2018// TI - Urine cell-based DNA methylation classifier for monitoring bladder cancer JO - Clin Epigenetics. VL - 10 UR - https://doi.org/10.1186/s13148-018-0496-x DO - 10.1186/s13148-018-0496-x ID - van der Heijden2018 ER - TY - JOUR AU - Su, S. F. AU - Castro Abreu, A. L. AU - Chihara, Y. AU - Tsai, Y. AU - Andreu-Vieyra, C. AU - Daneshmand, S. PY - 2014 DA - 2014// TI - A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrence JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2637 DO - 10.1158/1078-0432.CCR-13-2637 ID - Su2014 ER - TY - JOUR AU - Feber, A. AU - Dhami, P. AU - Dong, L. AU - Winter, P. AU - Tan, W. S. AU - Martinez-Fernandez, M. PY - 2017 DA - 2017// TI - UroMark-a urinary biomarker assay for the detection of bladder cancer JO - Clin Epigenetics. VL - 9 UR - https://doi.org/10.1186/s13148-016-0303-5 DO - 10.1186/s13148-016-0303-5 ID - Feber2017 ER - TY - JOUR AU - Ellinger, J. AU - Muller, S. C. AU - Dietrich, D. PY - 2015 DA - 2015// TI - Epigenetic biomarkers in the blood of patients with urological malignancies JO - Expert Rev Mol Diagn. VL - 15 UR - https://doi.org/10.1586/14737159.2015.1019477 DO - 10.1586/14737159.2015.1019477 ID - Ellinger2015 ER - TY - JOUR AU - Zhang, S. AU - Li, X. AU - Zong, M. AU - Zhu, X. AU - Wang, R. PY - 2018 DA - 2018// TI - Efficient kNN classification with different numbers of nearest neighbors JO - IEEE Trans Neural Netw Learn Syst. VL - 29 UR - https://doi.org/10.1109/TNNLS.2017.2673241 DO - 10.1109/TNNLS.2017.2673241 ID - Zhang2018 ER - TY - JOUR AU - Wilkerson, M. D. AU - Hayes, D. N. PY - 2010 DA - 2010// TI - ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking JO - Bioinformatics VL - 26 UR - https://doi.org/10.1093/bioinformatics/btq170 DO - 10.1093/bioinformatics/btq170 ID - Wilkerson2010 ER - TY - JOUR AU - Yu, G. AU - Wang, L. G. AU - Han, Y. AU - He, Q. Y. PY - 2012 DA - 2012// TI - ClusterProfiler: an R package for comparing biological themes among gene clusters JO - OMICS VL - 16 UR - https://doi.org/10.1089/omi.2011.0118 DO - 10.1089/omi.2011.0118 ID - Yu2012 ER - TY - JOUR AU - Zhu, K. AU - Liu, Q. AU - Zhou, Y. AU - Tao, C. AU - Zhao, Z. AU - Sun, J. PY - 2015 DA - 2015// TI - Oncogenes and tumor suppressor genes: comparative genomics and network perspectives JO - BMC Genomics. VL - 16 UR - https://doi.org/10.1186/1471-2164-16-S7-S8 DO - 10.1186/1471-2164-16-S7-S8 ID - Zhu2015 ER - TY - JOUR AU - Chung, C. J. AU - Lee, H. L. AU - Chang, C. H. AU - Chang, H. AU - Liu, C. S. AU - Jung, W. T. PY - 2019 DA - 2019// TI - Measurement of urinary arsenic profiles and DNA hypomethylation in a case-control study of urothelial carcinoma JO - Arch Toxicol VL - 93 UR - https://doi.org/10.1007/s00204-019-02500-y DO - 10.1007/s00204-019-02500-y ID - Chung2019 ER - TY - JOUR AU - Baylin, S. B. AU - Jones, P. A. PY - 2011 DA - 2011// TI - A decade of exploring the cancer epigenome—biological and translational implications JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3130 DO - 10.1038/nrc3130 ID - Baylin2011 ER - TY - JOUR AU - Wolff, E. M. AU - Chihara, Y. AU - Pan, F. AU - Weisenberger, D. J. AU - Siegmund, K. D. AU - Sugano, K. PY - 2010 DA - 2010// TI - Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-1335 DO - 10.1158/0008-5472.CAN-10-1335 ID - Wolff2010 ER - TY - JOUR AU - Majewski, T. AU - Yao, H. AU - Bondaruk, J. AU - Chung, W. AU - Lee, S. AU - Lee, J. G. PY - 2019 DA - 2019// TI - Whole-organ genomic characterization of mucosal field effects initiating bladder carcinogenesis JO - Cell Rep. VL - 26 ID - Majewski2019 ER - TY - JOUR AU - Guan, B. AU - Xing, Y. AU - Xiong, G. AU - Cao, Z. AU - Fang, D. AU - Li, Y. PY - 2018 DA - 2018// TI - Predictive value of gene methylation for second recurrence following surgical treatment of first bladder recurrence of a primary upper-tract urothelial carcinoma JO - Oncol Lett. VL - 15 ID - Guan2018 ER - TY - JOUR AU - Olkhov-Mitsel, E. AU - Savio, A. J. AU - Kron, K. J. AU - Pethe, V. V. AU - Hermanns, T. AU - Fleshner, N. E. PY - 2017 DA - 2017// TI - Epigenome-wide DNA methylation profiling identifies differential methylation biomarkers in high-grade bladder cancer JO - Transl Oncol. VL - 10 UR - https://doi.org/10.1016/j.tranon.2017.01.001 DO - 10.1016/j.tranon.2017.01.001 ID - Olkhov-Mitsel2017 ER - TY - JOUR AU - Yang, Z. AU - Liu, A. AU - Xiong, Q. AU - Xue, Y. AU - Liu, F. AU - Zeng, S. PY - 2019 DA - 2019// TI - Prognostic value of differentially methylated gene profiles in bladder cancer JO - J Cell Physiol VL - 234 UR - https://doi.org/10.1002/jcp.28515 DO - 10.1002/jcp.28515 ID - Yang2019 ER - TY - JOUR AU - Kitchen, M. O. AU - Bryan, R. T. AU - Haworth, K. E. AU - Emes, R. D. AU - Luscombe, C. AU - Gommersall, L. PY - 2015 DA - 2015// TI - Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0137003 DO - 10.1371/journal.pone.0137003 ID - Kitchen2015 ER - TY - JOUR AU - Xylinas, E. AU - Hassler, M. R. AU - Zhuang, D. AU - Krzywinski, M. AU - Erdem, Z. AU - Robinson, B. D. PY - 2016 DA - 2016// TI - An epigenomic approach to improving response to neoadjuvant cisplatin chemotherapy in bladder cancer JO - Biomolecules. VL - 6 UR - https://doi.org/10.3390/biom6030037 DO - 10.3390/biom6030037 ID - Xylinas2016 ER - TY - JOUR AU - Stubendorff, B. AU - Wilhelm, K. AU - Posselt, K. AU - Catto, J. AU - Hartmann, A. AU - Bertz, S. PY - 2019 DA - 2019// TI - A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer JO - J Cancer Res Clin Oncol VL - 145 UR - https://doi.org/10.1007/s00432-018-02829-4 DO - 10.1007/s00432-018-02829-4 ID - Stubendorff2019 ER - TY - JOUR AU - Langle, Y. AU - Lodillinsky, C. AU - Belgorosky, D. AU - Sandes, E. O. AU - Eijan, A. M. PY - 2012 DA - 2012// TI - Role of peroxisome proliferator activated receptor-gamma in bacillus Calmette-Guerin bladder cancer therapy JO - J Urol VL - 188 UR - https://doi.org/10.1016/j.juro.2012.07.109 DO - 10.1016/j.juro.2012.07.109 ID - Langle2012 ER - TY - JOUR AU - Lin, M. S. AU - Huang, J. X. AU - Chen, W. C. AU - Zhang, B. F. AU - Fang, J. AU - Zhou, Q. PY - 2011 DA - 2011// TI - Expression of PPARgamma and PTEN in human colorectal cancer: an immunohistochemical study using tissue microarray methodology JO - Oncol Lett. VL - 2 UR - https://doi.org/10.3892/ol.2011.414 DO - 10.3892/ol.2011.414 ID - Lin2011 ER - TY - JOUR AU - Zhang, Z. AU - Xu, H. AU - Ji, J. AU - Shi, X. AU - Lyu, J. AU - Zhu, Y. PY - 2019 DA - 2019// TI - Heterogeneity of PTEN and PPAR-gamma in cancer and their prognostic application to bladder cancer JO - Exp Ther Med. VL - 18 ID - Zhang2019 ER - TY - JOUR AU - Wood, R. D. AU - Mitchell, M. AU - Sgouros, J. AU - Lindahl, T. PY - 2001 DA - 2001// TI - Human DNA repair genes JO - Science VL - 291 UR - https://doi.org/10.1126/science.1056154 DO - 10.1126/science.1056154 ID - Wood2001 ER - TY - JOUR AU - Shields, P. G. AU - Harris, C. C. PY - 1991 DA - 1991// TI - Molecular epidemiology and the genetics of environmental cancer JO - JAMA VL - 266 UR - https://doi.org/10.1001/jama.1991.03470050081027 DO - 10.1001/jama.1991.03470050081027 ID - Shields1991 ER - TY - JOUR AU - Xie, H. AU - Gong, Y. AU - Dai, J. AU - Wu, X. AU - Gu, J. PY - 2015 DA - 2015// TI - Genetic variations in base excision repair pathway and risk of bladder cancer: a case-control study in the United States JO - Mol Carcinog VL - 54 UR - https://doi.org/10.1002/mc.22073 DO - 10.1002/mc.22073 ID - Xie2015 ER - TY - JOUR AU - Cheng, S. AU - Wang, G. AU - Wang, Y. AU - Cai, L. AU - Qian, K. AU - Ju, L. PY - 2019 DA - 2019// TI - Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARgamma-mediated pathway in bladder cancer JO - Clin Sci VL - 133 UR - https://doi.org/10.1042/CS20190587 DO - 10.1042/CS20190587 ID - Cheng2019 ER - TY - JOUR AU - Massari, F. AU - Ciccarese, C. AU - Santoni, M. AU - Iacovelli, R. AU - Mazzucchelli, R. AU - Piva, F. PY - 2016 DA - 2016// TI - Metabolic phenotype of bladder cancer JO - Cancer Treat Rev VL - 45 UR - https://doi.org/10.1016/j.ctrv.2016.03.005 DO - 10.1016/j.ctrv.2016.03.005 ID - Massari2016 ER - TY - JOUR AU - Rodrigues, D. AU - Jeronimo, C. AU - Henrique, R. AU - Belo, L. AU - Lourdes, B. a. s. t. o. s. M. AU - Pinho, P. G. PY - 2016 DA - 2016// TI - Biomarkers in bladder cancer: a metabolomic approach using in vitro and ex vivo model systems JO - Int J Cancer VL - 139 UR - https://doi.org/10.1002/ijc.30016 DO - 10.1002/ijc.30016 ID - Rodrigues2016 ER - TY - JOUR AU - Yoo, C. B. AU - Jones, P. A. PY - 2006 DA - 2006// TI - Epigenetic therapy of cancer: past, present and future JO - Nat Rev Drug Discov. VL - 5 UR - https://doi.org/10.1038/nrd1930 DO - 10.1038/nrd1930 ID - Yoo2006 ER - TY - JOUR AU - Kubicek, S. AU - O’Sullivan, R. J. AU - August, E. M. AU - Hickey, E. R. AU - Zhang, Q. AU - Teodoro, M. L. PY - 2007 DA - 2007// TI - Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase JO - Mol Cell VL - 25 UR - https://doi.org/10.1016/j.molcel.2007.01.017 DO - 10.1016/j.molcel.2007.01.017 ID - Kubicek2007 ER - TY - JOUR AU - Segovia, C. AU - San Jose-Eneriz, E. AU - Munera-Maravilla, E. AU - Martinez-Fernandez, M. AU - Garate, L. AU - Miranda, E. PY - 2019 DA - 2019// TI - Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression JO - Nat Med VL - 25 UR - https://doi.org/10.1038/s41591-019-0499-y DO - 10.1038/s41591-019-0499-y ID - Segovia2019 ER - TY - JOUR AU - Zhang, H. AU - Qi, F. AU - Cao, Y. AU - Zu, X. AU - Chen, M. AU - Li, Z. PY - 2013 DA - 2013// TI - 5-Aza-2′-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line JO - Cancer Biother Radiopharm. VL - 28 UR - https://doi.org/10.1089/cbr.2012.1303 DO - 10.1089/cbr.2012.1303 ID - Zhang2013 ER -